Immunotherapy | Tumor

CURE’s immunotherapy page features the latest cancer news and updates on immunotherapy Through articles, videos, podcasts, and more, CURE brings readers the insights of experts, cancer survivors, patients, and advocates to ensure everyone is up to date in immunotherapy.

Immunotherapy Offers New Optimism for Patients With Merkel Cell Carcinoma

October 20th 2017, 10:41pm

Article

Although chemotherapy has been used to treat patients with Merkel cell carcinoma, immunotherapy agents show great promise, according to findings presented at the 2017 World Congress of Melanoma.

Excitement Grows for Immunotherapy in Lung Cancer

October 14th 2017, 7:45pm

Article

A number of patients with lung cancer have benefitted from immunotherapy agents, and researchers in the field are excited that these treatments will continue to improve the field.

Breaking Down Misconceptions About Glioblastoma

October 13th 2017, 8:30pm

Video

David Reardon, M.D., clinical director at the Center for Neuro-oncology at the Dana-Farber Cancer Institute, breaks down a common misconception that many people have about glioblastoma (GBM).

When to Stop Immunotherapy Treatment for Melanoma

October 2nd 2017, 5:47pm

Video

Yania Jansen, surgical trainee at Vrije Universiteit Brussel, in Brussels, Belgium, discusses the possibility of stopping treatment with Keytruda (pembrolizumab) for patients with melanoma.

Immunotherapy: Seeking a Cure With Caution

September 22nd 2017, 6:10am

Article

Immunotherapy agents are promising in the treatment of cancer, but also come with some awful side effects.

Keytruda Shows Benefit in Small Cell Lung Cancer

September 6th 2017, 5:43pm

Article

The immunotherapy agent Keytruda (pembrolizumab) had an overall response rate (ORR) of 33 percent in a recent trial including patients with extensive-stage small cell lung cancer (SCLC). Findings of the phase 1b KEYNOTE-028 trial were published in the Journal of Clinical Oncology.

Questions Remain on Immunotherapy Use in Lung Cancer

August 30th 2017, 11:00pm

Article

David R. Gandara, M.D., discusses the latest immunotherapy advances in lung cancer, as well as the next steps toward optimizing the use of these agents.

Glioblastoma Vaccine to Be Tested as Orphan Drug, Easing Clinical Trials Process

August 19th 2017, 1:30am

Article

The designation recognizes that the vaccine, an immunotherapy called SurVaxM, would treat a rare disease, defined as one that affects a patient population of less than 200,000 Americans. However, because it acts on a protein that appears in 80 percent of cancers generally, SurVaxM may have wider applications.

Immunotherapy Treatment Advances in Anal Cancer

August 3rd 2017, 5:34pm

Article

More personalized approaches are being developed to treat patients with metastatic disease.

When Cancer Says "I'll Be Back," It's No Idle Threat

July 25th 2017, 5:20am

Article

Scoring the big NED often leads to that "Terminator" voice whispering in your ear.